Goldman Predicts ‘At Least One’ Vaccine Approval Before The End Of 2020, Raises GDP Estimate

Goldman Sachs has grown more optimistic about the timing for a coronavirus vaccine saying it expects at least one treatment to be widely available by next year, leading the firm to raise its economic growth outlook for 2021.